Urgency of planning broad vaccine-like access to lenacapavir PrEP globally
13 October 2024. Related: Conference reports, Treatment access, HIV prevention and transmission.
R4P 2024 Lima
Impact on CD4 counts of once-monthly islatravir in PrEP studies: early macaque results with MK-8527 follow-on compound
9 October 2024. Related: Conference reports, Antiretrovirals, HIV prevention and transmission.
Lenacapavir PrEP in cisgender gay men, trans and gender-diverse people: results of the PURPOSE 2 study
9 October 2024. Related: Conference reports, HIV prevention and transmission.
HIVR4P 2024: Context of PrEP in Latin America
7 October 2024. Related: Conference reports, Treatment access, HIV prevention and transmission.
HIVR4P 2024: Introduction
7 October 2024. Related: Conference reports, Treatment access, HIV prevention and transmission.